Medifast (MED) Misses Q3 EPS by 2c, Q4 Guidance Falls Well Short of Consensus
Tweet Send to a Friend
Medifast (NYSE: MED) reported Q3 EPS of $1.32, $0.02 worse than the analyst estimate of $1.34. Revenue for the quarter ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
